Bruker Corp.

Bruker (Nasdaq:BRKR) shares ticked up today on third-quarter financial results that beat the consensus forecast.

Shares of BRKR rose 8.4% at $66.22 apiece as the market opened today.

The Billerica, Massachusetts-based company posted profits of $88.1 million for the quarter. That amounts to 59¢ per share on sales of $638.9 million for the three months ended Sept. 30, 2022.

Bruker ended the quarter with a 1.1% bottom-line gain year-over-year on sales growth of 4.9%.

Adjusted to exclude one-time items, earnings per share totaled 66¢. That registers 11¢ ahead of expectations on Wall Street. Sales beat analyst projections as well, as they expected revenues of $608.2 million.

“Bruker had a solid first nine months of 2022, with 10.7% organic revenue growth, 160 bps non-GAAP gross margin expansion and 80 bps non-GAAP operating margin expansion year-over-year, despite continued supply chain and geopolitical challenges,” Bruker President and CE…

Bruker Corp. (NSDQ:BRKR) posted first-quarter results today that beat the overall consensus on Wall Street and raised its full-year guidance as a result.

The Billerica, Mass.-based company reported profits of $56.7 million, or 37¢ per share, on sales of $554.7 million for the three months ended March 31, for a bottom-line gain of 440% sales growth of 30.83% compared with Q1 2020.

Adjusted to exclude one-time items, earnings per share were 44¢, 12¢ ahead of The Street, where analysts were looking for sales of $513.06 million.

“Bruker had an excellent start to 2021, with strong year-over-year revenue growth and remarkable operating performance improvements. During the quarter, we experienced strong revenue growth for our Project Accelerate products and solutions, particularly for proteomics and biopharma solutions, as well as for our core scientific instruments from strengthening academic, applied, industrial and semiconductor markets,” president and…